Presentation is loading. Please wait.

Presentation is loading. Please wait.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Published byShon Brown Modified over 5 years ago

Similar presentations

Presentation on theme: "Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H"— Presentation transcript:

1 Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty 
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H. Schipper, MD  The Annals of Thoracic Surgery  Volume 92, Issue 6, Pages (December 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Lymphadenectomy rates overall and by surgeon type over time.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H"

Similar presentations

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R

Daniel C. Thomas, MD, MPH, Brian N. Arnold, MD, Jessica R
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Thomas J. Birdas, MD, Richard P. M

Thomas J. Birdas, MD, Richard P. M
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption  Justin D. Blasberg, MD, Christopher W. Seder,

Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption  Justin D. Blasberg, MD, Christopher W. Seder,
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer  Shenhai Wei, MD, PhD,
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Spiral Tracheoplasty After Tangential Resection of Trachea

Spiral Tracheoplasty After Tangential Resection of Trachea
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Gal Levy, MD, Mark A. Cordes, MD, Alexander S. Farivar, MD, Ralph W

Gal Levy, MD, Mark A. Cordes, MD, Alexander S. Farivar, MD, Ralph W
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 
Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Similar presentations

Ads by Google